Cellectar Biosciences is based in Florham Park, New Jersey. It has raised $103M in total funding. Latest round: Growth.
Cellectar Biosciences funding overview
Cellectar Biosciences is based in Florham Park, New Jersey. Cellectar Biosciences has raised $103M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Growth announced in September 2023. The round record for Cellectar Biosciences runs through 2023; nothing later has been disclosed. Investors on record include Rosalind Advisors, AIGH Capital, ADAR1, Second Line, Nantahala Capital, AuGC. 6 distinct backers are named across the disclosed rounds.
Cellectar Biosciences at a glance
Total raised
$103M
Latest round
Growth
Latest round date
September 2023
Headquarters
Florham Park, New Jersey
Notable investors
Rosalind Advisors, AIGH Capital, ADAR1, Second Line, Nantahala Capital, AuGC
Frequently asked about Cellectar Biosciences funding
How much has Cellectar Biosciences raised?
Cellectar Biosciences has raised $103M in total disclosed funding across the rounds on record.
Who has invested in Cellectar Biosciences?
Rosalind Advisors, AIGH Capital, ADAR1, Second Line, Nantahala Capital, AuGC are named among the investors backing Cellectar Biosciences.
What was the latest Cellectar Biosciences funding round?
The most recent disclosed round is a Growth, announced in September 2023.
Where is Cellectar Biosciences based?
Cellectar Biosciences is based in Florham Park, New Jersey.
When did Cellectar Biosciences last raise?
The last disclosed Cellectar Biosciences round closed in September 2023 at Growth.
We update the Cellectar Biosciences record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Florham Park and their backers are listed below.
